37 results on '"Guimarães, Patricia O"'
Search Results
2. Antithrombotic Strategies According to Age: Insights from the AUGUSTUS Trial
3. Geographic disparity of pathophysiological coronary artery disease characteristics: Insights from ASET trials
4. Prasugrel Monotherapy After Percutaneous Coronary Intervention for Chronic Coronary Syndrome: Insights From ASET Pilot Studies
5. Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis.
6. High risk coronavirus disease 2019: The primary results of the CoronaHeart multi-center cohort study
7. Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial
8. Aspirin-Free Prasugrel Monotherapy Following Coronary Artery Stenting in Patients With Stable CAD: The ASET Pilot Study
9. Clinical outcomes and need for intensive care after non-ST-segment-elevation myocardial infarction
10. Prevalence of atrial fibrillation and stroke risk assessment based on telemedicine screening tools in a primary healthcare setting
11. Antithrombotic treatment gap among patients with atrial fibrillation and type 2 diabetes
12. Usefulness of Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Myocardial Infarction
13. Prasugrel Monotherapy After Percutaneous Coronary Intervention for Chronic Coronary Syndrome
14. PAR Antagonists
15. Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial
16. International normalized ratio control and subsequent clinical outcomes in patients with atrial fibrillation using warfarin
17. A 30-Day Pooled Analysis of Acetyl Salicylic Elimination Trials (ASET) in Brazil and Japan: Synergy Stent with Prasugrel Monotherapy Without Aspirin
18. Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy
19. Anticoagulation therapy and clinical outcomes in patients with recently diagnosed atrial fibrillation: Insights from the ARISTOTLE trial
20. Highlights from the Tenth International Symposium of Thrombosis and Anticoagulation (ISTA X), September 22 and 23, 2017, Salvador, Bahia, Brazil
21. TCTAP A-046 A 30-Day Pooled Analysis of Acetyl Salicylic Elimination Trials (ASET) In Brazil and Japan: Synergy Stent With Prasugrel Monotherapy Without Aspirin
22. Association of standard clinical and laboratory variables with red blood cell distribution width
23. Pooled analysis of adverse event collection from 4 acute coronary syndrome trials
24. CRT-100.33 A 30-Day Pooled Analysis of Acetyl Salicylic Elimination Trials (ASET) in Brazil and Japan: Synergy Stent with Prasugrel Monotherapy Without Aspirin
25. Highlights from the Ninth International Symposium of Thrombosis and Anticoagulation (ISTA IX), October 15, 2016, Salvador, Bahia, Brazil
26. Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES Trial
27. Antithrombotic therapy in the elderly: The more we know, the more we can offer
28. Reply
29. Association between perivascular inflammation and downstream myocardial perfusion in patients with suspected coronary artery disease
30. Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial
31. Reply: Elimination of Aspirin From PCI Pharmacotherapy
32. Acute Coronary Syndrome After Ondansetron Administration in a Pregnant Woman: Kounis Syndrome?
33. Accuracy of Medical Claims for Identifying Cardiovascular and Bleeding Events After Myocardial Infarction
34. Corrigendum to ‘Association of Standard Clinical and Laboratory Variables with Red Blood Cell Distribution Width (RDW)’[Am. Heart J. (2016) 22–28]
35. P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients with acute coronary syndromes undergoing coronary stenting: rationale and design of the NEOMINDSET Trial.
36. Aspirin should be stopped at day 0 after PCI: pros and cons.
37. Association between perivascular inflammation and downstream myocardial perfusion in patients with suspected coronary artery disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.